freya semaglutide reviews Week 4 with @freya.meds and I'm down 10lbs 🤯 I was Freya Meds GLP-1: Provider-Guided Weight

These include: Severe headaches , particularly if sudden-onset or different from usual patterns Visual disturbances such as blurred vision or seeing spots Chest pain or pressure , which may indicate cardiovascular complications (call 911) Shortness of breath or difficulty breathing, especially with exertion (call 911 if severe) Neurological symptoms including facial drooping, arm weakness, speech difficulties (call 911) Severe dizziness or lightheadedness , particularly upon standing (suggesting hypotension) Nosebleeds that are difficult to control Confusion or difficulty concentrating Patients should also promptly report semaglutide-specific concerns that may require immediate evaluation: Severe, persistent abdominal pain (possible pancreatitis) Right upper quadrant pain, fever, or yellowing of skin/eyes (possible gallbladder disease) Signs of allergic reaction including rash, swelling, or difficulty breathing New or worsening vision problems (potential diabetic retinopathy complications) Persistent nausea, vomiting, or diarrhea can lead to dehydration, electrolyte imbalances, and secondary blood pressure changes

This approach is consistent with other GLP-1-based therapies and is designed to minimise gastrointestinal side effects whilst allowing the body to adjust gradually to the medication

and inter alia, further down-regulates insulin function and thereby exacerbates Metabolic Syndrome!

Activation of microglia in the trigeminal nucleus caudalis (TNC) contributes to this progression